Vanda Pharmaceuticals Inc (VNDA)
4.06
-0.06
(-1.46%)
USD |
NASDAQ |
Apr 15, 16:00
3.96
-0.10
(-2.46%)
After-Hours: 05:35
Vanda Pharmaceuticals Cash from Operations (TTM): 12.80M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.80M |
| September 30, 2023 | 25.95M |
| June 30, 2023 | 40.84M |
| March 31, 2023 | 59.74M |
| December 31, 2022 | 31.98M |
| September 30, 2022 | 49.18M |
| June 30, 2022 | 45.74M |
| March 31, 2022 | 59.07M |
| December 31, 2021 | 64.21M |
| September 30, 2021 | 56.91M |
| June 30, 2021 | 56.89M |
| March 31, 2021 | 61.88M |
| December 31, 2020 | 51.78M |
| September 30, 2020 | 42.26M |
| June 30, 2020 | 38.89M |
| March 31, 2020 | 35.40M |
| December 31, 2019 | 45.95M |
| September 30, 2019 | 51.42M |
| June 30, 2019 | 54.12M |
| March 31, 2019 | 37.99M |
| December 31, 2018 | 29.99M |
| September 30, 2018 | 18.19M |
| June 30, 2018 | 11.66M |
| March 31, 2018 | 5.012M |
| December 31, 2017 | -1.983M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.632M |
| June 30, 2017 | -7.559M |
| March 31, 2017 | -8.561M |
| December 31, 2016 | -8.103M |
| September 30, 2016 | -7.276M |
| June 30, 2016 | -13.37M |
| March 31, 2016 | 1.995M |
| December 31, 2015 | 12.45M |
| September 30, 2015 | -0.581M |
| June 30, 2015 | -3.329M |
| March 31, 2015 | -52.10M |
| December 31, 2014 | -81.55M |
| September 30, 2014 | -80.32M |
| June 30, 2014 | -82.99M |
| March 31, 2014 | -54.37M |
| December 31, 2013 | -39.59M |
| September 30, 2013 | -41.29M |
| June 30, 2013 | -41.18M |
| March 31, 2013 | -45.35M |
| December 31, 2012 | -44.92M |
| September 30, 2012 | -43.42M |
| June 30, 2012 | -40.43M |
| March 31, 2012 | -33.84M |
| December 31, 2011 | -28.41M |
| September 30, 2011 | -21.15M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
12.80M
Minimum
Dec 2023
64.21M
Maximum
Dec 2021
46.58M
Average
49.18M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| ADMA Biologics Inc | 8.80M |
| Johnson & Johnson | 22.79B |
| Nektar Therapeutics | -192.61M |
| Invivyd Inc | -173.16M |
| Amicus Therapeutics Inc | -69.09M |